Palmitoylethanolamide (PEA)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Palmitoylethanolamide (PEA), covering 2024-11-14 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial